PT  - JOURNAL ARTICLE
AU  - Levy, Corinne
AU  - Basmaci, Romain
AU  - Bensaid, Philippe
AU  - Bru, Cécile Bost
AU  - Coinde, Edeline
AU  - Dessioux, Emmanuelle
AU  - Fournial, Cécile
AU  - Gashignard, Jean
AU  - Haas, Hervé
AU  - Hentgen, Véronique
AU  - Huet, Frédéric
AU  - Lalande, Muriel
AU  - Martinot, Alain
AU  - Pons, Charlotte
AU  - Romain, Anne Sophie
AU  - Ursulescu, Nicoleta
AU  - Sage, François Vie Le
AU  - Raymond, Josette
AU  - Béchet, Stéphane
AU  - Toubiana, Julie
AU  - Cohen, Robert
TI  - Changes in RT-PCR-positive SARS-CoV-2 rates in adults and children according to the epidemic stages
AID  - 10.1101/2020.05.18.20098863
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.18.20098863
4099  - http://medrxiv.org/content/early/2020/06/09/2020.05.18.20098863.short
4100  - http://medrxiv.org/content/early/2020/06/09/2020.05.18.20098863.full
AB  - Aim To describe the trends of RT-PCR positive SARS-CoV-2 rates in children and adults according to the time of COVID-19 epidemic.Methods In this prospective multicenter study involving 45 pediatric units, we collected the results of nasopharyngeal swabs in France from March 2, 2020 to April 26, 2020.Results During the study period, 52,588 RT-PCR tests for SARS-CoV-2 were performed, 6,490 in children and 46,098 in adults. The risk ratio of RT-PCR positive SARS-CoV-2 tests for adults compared to children was 3.5 (95% CI [3.2;3.9]) for the whole study period. These rates varied according to the time of the epidemic and were higher at the peak. The lower rates of positive test in children persisted during the surveillance period but varied according to the time in the epidemic.Conclusion The rate of positive RT-PCR positive SARS-CoV-2 tests for children was always less than that for adults but vary according to the epidemic stage.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot registeredFunding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The GFHGNP (Groupe Francophone Hepatologie et Nutrition Pediatrique) Ethics Comittee, certifies that this study Surveillance of SARS CoV2 positive PCR in France performed by the GPIP ACTIV does not required any ethical approval due to the absence of personal dataAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata are available upon reasonable request